Skip to main content
Fig. 4 | BMC Genomics

Fig. 4

From: Predicting tumor response to drugs based on gene-expression biomarkers of sensitivity learned from cancer cell lines

Fig. 4

Predicted sensitivity based on mutation status. Violin plots of predicted ln (IC50) values of trametinib based on RNA-seq gene expression data from TCGA tumor samples for those with and without mutations in BRAF a, KRAS b and NRAS c. * p < 0.05; ** p < 0.005; **** p < 10− 6. Wilcoxon rank-sum test, two-sided

Back to article page

BMC Genomics

ISSN: 1471-2164

Contact us